companies developing glp 1 drugs GLP-1 2.0: Where the Next Wave of Value Will Be Created FDA says that the GLP-1

Wenn sie in die Kategorie der schwerwiegenden unerwnschten Ereignisse fallen, mssen sie den Behrden der Lnder, in denen die Studie stattfindet, gemeldet werden (MDR und Leitfaden MDCG 2020-10/1 "Safety reporting in clinical examinations of medical devices under the Regulation (EU) 2017/745")

It helps the body release insulin when glucose levels rise, reduces excess glucose production from the liver, slows stomach emptying, and increases feelings of fullness

doi:10.1016/j.jacc.2019.11.060 68

This damage can lead to various forms of hair loss, including androgenetic alopecia (commonly known as male or female pattern baldness) and telogen effluviumconditions that can significantly affect self-esteem and overall well-being